Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02017379 · ClinicalTrials.gov registry record · NA
Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.
A NA study, sponsored by Texas Tech University Health Sciences Center, El Paso.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02017379 is a NA study that was terminated before completion, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 4 participants.
The verdict
NCT02017379, a NA study, was terminated before completion, sponsored by Texas Tech University Health Sciences Center, El Paso.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This is a study comparing the effect of erythromycin or metoclopramide, 2 prokinetic drugs (Drugs which are known to speed up the emptying of the stomach or in other words to move the blood out of the stomach faster) given before endoscopy to patients with upper Gastrointestinal bleeding compared to patients who will not receive either of these medications before their endoscopy.
Interventions
- DRUG Erythromycin
- DRUG Metoclopromide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-06 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02017379
The ClinicalTrials.gov registry entry for NCT02017379 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, El Paso, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Erythromycin is the first listed.
NCT02017379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02017379 about?
NCT02017379 is a clinical study titled "Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.". This is a study comparing the effect of erythromycin or metoclopramide, 2 prokinetic drugs (Drugs which are known to speed up the emptying of the stomach or in other words to move the blood out of the stomach faster) given before endoscopy to patients with upper Gastrointestinal bleeding compared to...
What is the current status of trial NCT02017379?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2014-06. Estimated completion is 2014-09.
What interventions are being tested in trial NCT02017379?
The interventions under investigation include: Erythromycin (DRUG), Metoclopromide (DRUG).
Who is sponsoring clinical trial NCT02017379?
This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.